Quarterly report · Q1

Period2024-01-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥5.6bn2024-01-01 → 2024-03-31Cons.Net sales
Revenue¥20.4bn2023-01-01 → 2023-12-31Cons.Net sales (5-year summary)
Revenue¥4.9bn2023-01-01 → 2023-03-31Cons.Net sales
Operating income¥720m2024-01-01 → 2024-03-31Cons.Operating income
Operating income¥851m2023-01-01 → 2023-03-31Cons.Operating income
Ordinary income¥873m2024-01-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥2.9bn2023-01-01 → 2023-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥961m2023-01-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥848m2024-01-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥820m2023-01-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥571m2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥511m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥584m2024-01-01 → 2024-03-31Cons.Profit loss
Net income¥509m2023-01-01 → 2023-03-31Cons.Profit loss
Total assets¥29.8bnat 2024-03-31Cons.Assets
Total assets¥29.4bnat 2023-12-31Cons.Assets
Total assets¥26.7bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥9.4bnat 2024-03-31Cons.Liabilities
Total liabilities¥8.8bnat 2023-12-31Cons.Liabilities
Net assets / equity¥20.4bnat 2024-03-31Cons.Net assets
Net assets / equity¥20.6bnat 2023-12-31Cons.Net assets
Net assets / equity¥19.5bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥9.5bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥9.4bnat 2023-12-31Cons.Cash and deposits
EPS (basic)¥8.12024-01-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.762023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.242023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥8.082024-01-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥27.682023-01-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥7.222023-01-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio68.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio69.6%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio72.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Otherother segmentsrevenue2024-01-01 → 2024-03-31¥299m
Otherother segmentsrevenue external2024-01-01 → 2024-03-31¥271m
Otherother segmentsrevenue intersegment2024-01-01 → 2024-03-31¥27m
Otherother segmentssegment profit2024-01-01 → 2024-03-31¥36m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥32m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥32m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥12m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥139m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥139m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥104m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥596m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥596m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥86m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥4.6bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥4.6bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥4m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2024-01-01 → 2024-03-31¥863m
—segment totalrevenue2024-01-01 → 2024-03-31¥5.6bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥5.6bn
—segment totalrevenue intersegment2024-01-01 → 2024-03-31¥32m
—segment totalsegment profit2024-01-01 → 2024-03-31¥708m
Otherother segmentsrevenue2023-01-01 → 2023-03-31¥187m
Otherother segmentsrevenue external2023-01-01 → 2023-03-31¥167m
Otherother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥19m
Otherother segmentssegment profit2023-01-01 → 2023-03-31¥2m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥24m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥13m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥140m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥140m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥108m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥791m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥791m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥51m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥3.8bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥3.8bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥5m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥892m
—segment totalrevenue2023-01-01 → 2023-03-31¥4.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥4.9bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥24m
—segment totalsegment profit2023-01-01 → 2023-03-31¥838m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 368
ItemContextValueUnit
Foreign currency translation adjustmentPrior1YearInstant106000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant134000000JPY
Valuation and translation adjustmentsPrior1YearInstant191000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant180000000JPY
Subscription rights to sharesPrior1YearInstant56000000JPY
Subscription rights to sharesCurrentQuarterInstant55000000JPY
Non controlling interestsPrior1YearInstant45000000JPY
Non controlling interestsCurrentQuarterInstant58000000JPY
Net assetsPrior1YearInstant20566000000JPY
Net assetsCurrentQuarterInstant20441000000JPY
Liabilities and net assetsPrior1YearInstant29387000000JPY
Liabilities and net assetsCurrentQuarterInstant29804000000JPY
Net salesPrior1YTDDuration4877000000JPY
Net salesCurrentYTDDuration5571000000JPY
Cost of salesPrior1YTDDuration2232000000JPY
Cost of salesCurrentYTDDuration2649000000JPY
Gross profitPrior1YTDDuration2645000000JPY
Gross profitCurrentYTDDuration2922000000JPY
Selling general and administrative expensesPrior1YTDDuration1793000000JPY
Selling general and administrative expensesCurrentYTDDuration2201000000JPY
Operating incomePrior1YTDDuration851000000JPY
Operating incomeCurrentYTDDuration720000000JPY
Interest income noiPrior1YTDDuration1000000JPY
Interest income noiCurrentYTDDuration2000000JPY
Rent income of real estate noiPrior1YTDDuration251000000JPY
Rent income of real estate noiCurrentYTDDuration260000000JPY
Other noiPrior1YTDDuration5000000JPY
Other noiCurrentYTDDuration4000000JPY
Non operating incomePrior1YTDDuration258000000JPY
Non operating incomeCurrentYTDDuration267000000JPY
Interest expenses noePrior1YTDDuration3000000JPY
Interest expenses noeCurrentYTDDuration3000000JPY
Rent expenses on real estates noePrior1YTDDuration108000000JPY
Rent expenses on real estates noeCurrentYTDDuration104000000JPY
Equity in losses of affiliates noePrior1YTDDuration35000000JPY
Equity in losses of affiliates noeCurrentYTDDuration-JPY
Other noePrior1YTDDuration1000000JPY
Other noeCurrentYTDDuration6000000JPY
Non operating expensesPrior1YTDDuration148000000JPY
Non operating expensesCurrentYTDDuration114000000JPY
Ordinary incomePrior1YTDDuration961000000JPY
Ordinary incomeCurrentYTDDuration873000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration0JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration25000000JPY
Loss on step acquisitions elPrior1YTDDuration140000000JPY
Loss on step acquisitions elCurrentYTDDuration-JPY
Extraordinary lossPrior1YTDDuration141000000JPY
Extraordinary lossCurrentYTDDuration25000000JPY
Income before income taxesPrior1YTDDuration820000000JPY
Income before income taxesCurrentYTDDuration848000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass